Vasopressin-stimulated release of atriopeptin: Endocrine antagonists in fluid homeostasis

Pamela T. Manning, David Schwartz, Nobuo C. Katsube, Sandra W. Holmberg, Philip Needleman

Research output: Contribution to journalArticlepeer-review

253 Scopus citations


Administration of pharmacological doses of arginine-vasopressin, related peptides, and other pressor agents induced a profound release of atriopeptin immunoreactivity into the circulation. The stimulated release of atriopeptin apparently was related to increased arterial blood pressure. Neither the nonpressor vasopressin analog 1-deamino-D-Arg8-vasopressin nor arginine-vasopressin in the presence of a specific pressor antagonist caused atriopeptin to be released into the circulation. Urine output was correlated with the level of atriopeptin released. Physiological levels of arginine-vasopressin suppress diuresis and produced vasoconstriction. Pharmacological levels of the hormone stimulated the cardiac endocrine system to release atriopeptin, which may cause diuresis and vasodilation to physiologically antagonize the effects of vasopressin.

Original languageEnglish
Pages (from-to)395-397
Number of pages3
Issue number4711
StatePublished - 1985


Dive into the research topics of 'Vasopressin-stimulated release of atriopeptin: Endocrine antagonists in fluid homeostasis'. Together they form a unique fingerprint.

Cite this